Metabolism-induced tumor activator 1 (MITA1)

Metabolism-induced tumor activator 1 (MITA1) is a long non-coding RNA (lncRNA) that is upregulated in response to cellular metabolic stress and is notably induced in hepatocellular carcinoma and other aggressive solid tumors. Functionally, MITA1 appears to contribute to tumor progression by facilitating the epithelial-mesenchymal transition (EMT), thereby promoting metastasis. It may also participate in the tumor microenvironment by modulating the activity of NFκB signaling pathways, which are critical for inflammation and immune response in cancer progression. MITA1 is not a canonical receptor, enzyme, transporter, or transcription factor, but rather an lncRNA that acts at the post-transcriptional level. There are currently no known drugs that directly target MITA1, nor detailed mechanisms of action for targeted molecules, but its involvement in EMT and immune regulation suggests it may be a potential therapeutic target or biomarker for cancer research and therapy.

Other names

MITA1metabolism-induced tumor activator 1hNAILNFκB associated immunoregulatory long non-coding RNA